|
|
||||||||
Currently there are no commercially available selective media indicated for the isolation of Burkholderia mallei and Burkholderia pseudomallei. Ashdowns agar, a custom selective medium for isolation of B. pseudomallei, is well described in the literature but unavailable commercially. Three commercially available media, Burkholderia cepacia selective agar (BCSA), oxidative-fermentative-polymyxin B-bacitracin-lactose (OFPBL) agar, and Pseudomonas cepacia (PC) agar are recommended for isolation of B. cepacia from respiratory secretions of cystic fibrosis patients. We evaluated the sensitivity and selectivity of these four media using 20 B. mallei, 20 B. pseudomallei, 20 Burkholderia spp., and 15 diagnostically challenging organisms. Ashdowns agar was the most sensitive medium for the isolation of B. pseudomallei, but it was unable to support growth of B. mallei. Pseudomonas cepacia agar was highly sensitive and selective for both organisms. In non-endemic areas, we suggest the use of the commercially available PC agar for the isolation of B. mallei and B. pseudomallei.
Received August 25, 2008. Accepted for publication February 15, 2009.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
* Address correspondence to Mindy B. Glass, Centers for Disease Control and Prevention, National Center for Zoonotic, Vector-borne and Enteric Diseases, Division of Foodborne, Bacterial and Mycotic Diseases, Bacterial Zoonoses Branch, 1600 Clifton Road, MS G-34, Atlanta, GA 30333. E-mail: mglass{at}cdc.gov
Authors addresses: Mindy B. Glass, Cari A. Beesley, Patricia P. Wilkins, and Alex R. Hoffmaster, Centers for Disease Control and Prevention, National Center for Zoonotic, Vector-borne and Enteric Diseases, Division of Foodborne, Bacterial and Mycotic Diseases, Bacterial Zoonoses Branch, 1600 Clifton Road, MS G-34, Atlanta, GA 30333, Tel: 404-639-4055, Fax: 404-639-3023, E-mail: mglass{at}cdc.gov.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |